Cti Biopharm Corp (CTIC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
9.09 unch (unch) 06/23/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 9.09 unch (unch) -
for Fri, Jun 23rd, 2023
Results
download Want to compare other data? Select Fields| Symbol | CTIC | OCUL | EVO | ||
| Company | Cti Biopharm Corp | Ocular Therapeut | Evotec Se | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.10 | 7.52 | 3.39 | ||
| High | 9.10 | 7.82 | 3.40 | ||
| Low | 9.09 | 7.27 | 3.33 | ||
| Last | 9.09 | 7.53 | 3.37 | ||
| Change | unch | -0.04 | +0.07 | ||
| % Change | unch | -0.53% | +2.12% | ||
| Volume | 11,420,900 | 2,008,900 | 65,300 | ||
| 20-Day Average Volume | 3,402,150 | 1,858,570 | 100,530 | ||
| Previous Close | 9.09 | 7.57 | 3.30 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 9.06 | 7.16 | 3.31 | ||
| 20-Day Raw Stochastic | 88.89% | 77.23% | 64.63% | ||
| 20-Day Relative Strength | 80.92% | 51.90% | 45.01% | ||
| Weighted Alpha | +5.50 | +16.47 | -41.82 | ||
| Today's Opinion | 100% Buy | 72% Sell | 72% Sell | ||
| Previous Opinion | 100% Buy | 72% Sell | 88% Sell | ||
| Last Month's Opinion | 48% Buy | 40% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 06/15/23 | +25.08% since 04/08/25 | +10.86% since 04/08/25 | ||
| Low | 9.07 on 06/20/23 | 5.80 on 04/09/25 | 2.95 on 04/09/25 | ||
| High | 9.10 on 06/23/23 | 7.82 on 04/15/25 | 3.40 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | +1.11% since 05/23/23 | -2.46% since 03/14/25 | -3.99% since 03/14/25 | ||
| Low | 8.98 on 05/24/23 | 5.80 on 04/09/25 | 2.84 on 04/07/25 | ||
| High | 9.10 on 06/23/23 | 8.25 on 03/18/25 | 3.68 on 03/18/25 | ||
| 3-Month | |||||
| %Chg | +111.40% since 03/23/23 | -7.38% since 01/15/25 | -17.80% since 01/15/25 | ||
| Low | 4.01 on 04/06/23 | 5.78 on 03/04/25 | 2.84 on 04/07/25 | ||
| High | 9.10 on 06/23/23 | 8.92 on 03/12/25 | 4.76 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | +61.46% since 12/23/22 | -26.39% since 10/15/24 | +16.21% since 10/15/24 | ||
| Low | 4.01 on 04/06/23 | 5.78 on 03/04/25 | 2.84 on 04/07/25 | ||
| High | 9.10 on 06/23/23 | 11.77 on 10/28/24 | 5.64 on 11/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,198,789 | 1,203,797 | 1,171,853 | ||
| Shares Outstanding, K | 131,880 | 159,022 | 355,107 | ||
| Annual Sales | 53,950,000 | 63,720,000 | 845,740,000 | ||
| Annual Net Income | -92,990,000 | -193,510,000 | -90,820,000 | ||
| Last Quarter Sales | 24,120,000 | 17,080,000 | 203,310,000 | ||
| Last Quarter Net Income | -13,420,000 | -48,390,000 | -43,580,000 | ||
| 60-Month Beta | 0.83 | 1.49 | 1.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 05/15/23 | -0.29 on 03/03/25 | N/A on 11/06/24 | ||
| Latest Earnings Date | 08/14/23 | 05/06/25 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||